RNA Details
                    Disease Name
                    
                    pulmonary arterial hypertension
                    
                    Tissue
                    
                    lung
                    
                    RNA Symbol
                    
                    Ptpn11
                    
                RNA ID
                    
                    
                    
                RNA Type
                    
                    mRNA
                    
                Alteration Pattern
                    
                    down regulation
                    
                Species
                    
                    rattus norvegicus
                    
                Detection Methods
                    
                    TLDAS; qRT-PCR; Dual-luciferase reporter assay etc.
                    
                Target
                    
                    Shp2
                    
                Pathway
                    
                    STAT3-MIR-204-SRC-STAT3-NFAT signaling pathway?
                    
                PubMed ID
                    
                    
                    
                    
                    
                Title
                    
                    Role for miR-204 in human pulmonary arterial hypertension
                    
                Year
                    
                     2011
                    
                Function
                    
                    "MiR-204 expression in PASMCs is down-regulated in both human and rodent PAH. MiR-204 down-regulation correlates with PAH severity and accounts for the proliferative and antiapoptotic phenotypes of PAH-PASMCs. STAT3 activation suppresses miR-204 expression, and miR-204 directly targets SHP2 expression, thereby SHP2 up-regulation, by miR-204 down-regulation, activates the Src kinase and nuclear factor of activated T cells (NFAT). STAT3 also directly induces NFATc2 expression. NFAT and SHP2 were needed to sustain PAH-PASMC proliferation and resistance to apoptosis. Finally, delivery of synthetic miR-204 to the lungs of animals with PAH significantly reduced disease severity."